The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health
Open accessAbstract
The emergence of carbapenemase producing bacteria, especially New Delhi metallo-β-lactamase (NDM-1) and its variants, worldwide, has raised amajor public health concern. NDM-1 hydrolyzes a wide range of β-lactam antibiotics, including carbapenems, which are the last resort of antibiotics for the treatment of infections caused by resistant strain of bacteria. In this review, we have discussed bla NDM-1variants, its genetic analysis including type of specific mutation, origin of country and spread among several type of bacterial species. Wide members of enterobacteriaceae, most commonly Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, and gram-negative non-fermenters Pseudomonas spp. and Acinetobacter baumannii were found to carry these markers. Moreover, at least seventeen variants of bla NDM-type gene differing into one or two residues of amino acids at distinct positions have been reported so far among different species of bacteria from different countries. The genetic and structural studies of these variants are important to understand the mechanism of antibiotic hydrolysis as well as to design new molecules with inhibitory activity against antibiotics. This review provides a comprehensive view of structural differences among NDM-1 variants, which are a driving force behind their spread across the globe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Phylogeny.fr: robust phylogenetic analysis for the non-specialist
Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., Dufayard, J.-F., Guindon, S., Lefort, V., Lescot, M., et al. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn180 · Cited by 4,700
Silhavy, T. J., Kahne, D., & Walker, S. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000414 · Cited by 3,798
Kumarasamy, K. K., Toleman, M. A., Walsh, T. R., Bagaria, J., Butt, F., Balakrishnan, R., Chaudhary, U., Doumith, M., Giske, C. G., Irfan, S., et al. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70143-2 · Cited by 2,922
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367
Identification of plasmids by PCR-based replicon typing
Carattoli, A., Bertini, A., Villa, L., Falbo, V., Hopkins, K. L., & Threlfall, E. J. (2005) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2005.03.018 · Cited by 2,319
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Hypervirulent (hypermucoviscous)Klebsiella pneumoniae: A new and dangerous breed
Shon, A. S., Bajwa, R. P. S., & Russo, T. A. (2013) · Virulence · doi:10.4161/viru.22718 · Cited by 1,171
Bacterial resistance to antibiotics: Enzymatic degradation and modification
WRIGHT, G. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.002 · Cited by 897
BLAST-EXPLORER helps you building datasets for phylogenetic analysis
Dereeper, A., Audic, S., Claverie, J.-M., & Blanc, G. (2010) · BMC Evolutionary Biology · doi:10.1186/1471-2148-10-8 · Cited by 744
Has the era of untreatable infections arrived?
Livermore, D. M. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp255 · Cited by 620
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens
Pfeifer, Y., Cullik, A., & Witte, W. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.04.005 · Cited by 494
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
The emergence of antibiotic resistance by mutation
Woodford, N., & Ellington, M. J. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01492.x · Cited by 417 · cited 1×
“The possible reason for evolving trends of new markers is mutations [1], which may cause delaying in the discovery of new antibiotics for treatments and hence became a great public threat [2].”
BackgroundGenetic Features of bla NDM-1 -Positive Enterobacteriaceae
Poirel, L., Dortet, L., Bernabeu, S., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00585-11 · Cited by 404
Hornsey, M., Phee, L., & Wareham, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05108-11 · Cited by 392
New antibiotic agents in the pipeline and how they can help overcome microbial resistance
Gould, I. M., & Bal, A. M. (2013) · Virulence · doi:10.4161/viru.22507 · Cited by 363
Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues
Miriagou, V., Cornaglia, G., Edelstein, M., Galani, I., Giske, C. G., Gniadkowski, M., Malamou-Lada, E., Martinez-Martinez, L., Navarro, F., Nordmann, P., et al. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03116.x · Cited by 350
Gilbert, P., & McBain, A. J. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.2.189-208.2003 · Cited by 334
Livermore, D. M. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1465-0691.2004.1004.x · Cited by 314
Multidrug resistant commensal Escherichia coli in animals and its impact for public health
Szmolka, A., & Nagy, B. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00258 · Cited by 314
Köhler, T., Michea-Hamzehpour, M., Epp, S. F., & Pechere, J.-C. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.424 · Cited by 268
Martínez-Martínez, L., Pascual, A., Hernández-Allés, S., Alvarez-Díaz, D., Suárez, A. I., Tran, J., Benedí, V. J., & Jacoby, G. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1669 · Cited by 250
Carbapenem-resistant and colistin-resistant Escherichia coli co-producing NDM-9 and MCR-1
Yao, X., Doi, Y., Zeng, L., Lv, L., & Liu, J.-H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00057-8 · Cited by 245
New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?
Rolain, J. M., Parola, P., & Cornaglia, G. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03385.x · Cited by 238
NDM-2 carbapenemase in Acinetobacter baumannii from Egypt
Kaase, M., Nordmann, P., Wichelhaus, T. A., Gatermann, S. G., Bonnin, R. A., & Poirel, L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr135 · Cited by 231
Kazmierczak, K. M., Rabine, S., Hackel, M., McLaughlin, R. E., Biedenbach, D. J., Bouchillon, S. K., Sahm, D. F., & Bradford, P. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02379-15 · Cited by 220
B1-Metallo-β-Lactamases: Where Do We Stand?
F. Mojica, M., A. Bonomo, R., & Fast, W. (2016) · Current Drug Targets · doi:10.2174/1389450116666151001105622 · Cited by 215
Bush, K. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.08.011 · Cited by 188
Emergence of NDM-1 Metallo-β-Lactamase in Pseudomonas aeruginosa Clinical Isolates from Serbia
Jovcic, B., Lepsanovic, Z., Suljagic, V., Rackov, G., Begovic, J., Topisirovic, L., & Kojic, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00226-11 · Cited by 184
Intestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance Methods
Viau, R., Frank, K. M., Jacobs, M. R., Wilson, B., Kaye, K., Donskey, C. J., Perez, F., Endimiani, A., & Bonomo, R. A. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00108-14 · Cited by 181
Global spread of New Delhi metallo-β-lactamase 1
Hammerum, A. M., Toleman, M. A., Hansen, F., Kristensen, B., Lester, C. H., Walsh, T. R., & Fuursted, K. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70276-0 · Cited by 173
Poirel, L., Bonnin, R. A., & Nordmann, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-11 · Cited by 169
Dissemination of New Delhi metallo-β-lactamase-1-producing Acinetobacter baumannii in Europe
Bonnin, R. A., Poirel, L., Naas, T., Pirš, M., Seme, K., Schrenzel, J., & Nordmann, P. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03928.x · Cited by 167
Thabit, A. K., Crandon, J. L., & Nicolau, D. P. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.993381 · Cited by 160
Rahman, M., Shukla, S. K., Prasad, K. N., Ovejero, C. M., Pati, B. K., Tripathi, A., Singh, A., Srivastava, A. K., & Gonzalez-Zorn, B. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.03.003 · Cited by 159
Hu, H., Hu, Y., Pan, Y., Liang, H., Wang, H., Wang, X., Hao, Q., Yang, X., Yang, X., Xiao, X., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06199-11 · Cited by 143
Risk factors and clinical outcomes for carbapenem-resistant Enterobacteriaceae nosocomial infections
Wang, Q., Zhang, Y., Yao, X., Xian, H., Liu, Y., Li, H., Chen, H., Wang, X., Wang, R., Zhao, C., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2710-0 · Cited by 141
Antibiotic resistance in China—a major future challenge
Heddini, A., Cars, O., Sun, Q., & Tomson, G. B. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61956-x · Cited by 129
Mechanistic and Spectroscopic Studies of Metallo-β-lactamase NDM-1
Yang, H., Aitha, M., Hetrick, A., Richmond, T. K., Tierney, D. L., & Crowder, M. W. (2012) · Biochemistry · doi:10.1021/bi300056y · Cited by 114
Joshi, P. R., Acharya, M., Kakshapati, T., Leungtongkam, U., Thummeepak, R., & Sitthisak, S. (2017) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-017-0180-5 · Cited by 110
Sidjabat, H. E., Townell, N., Nimmo, G. R., George, N., Robson, J. M. B., Vohra, R., Davis, L., Heney, C., & Paterson, D. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04378-14 · Cited by 98
Campos, J. C., da Silva, M. J. F., dos Santos, P. R. N., Barros, E. M., Pereira, M. D. O., Seco, B. M. S., Magagnin, C. M., Leiroz, L. K., de Oliveira, T. G. M., Faria-Junior, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01458-15 · Cited by 95
Transposition of Tn 125 Encoding the NDM-1 Carbapenemase in Acinetobacter baumannii
Bontron, S., Nordmann, P., & Poirel, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01755-16 · Cited by 89
Sahl, J. W., Franco, M. D., Pournaras, S., Colman, R. E., Karah, N., Dijkshoorn, L., & Zarrilli, R. (2015) · Scientific Reports · doi:10.1038/srep15188 · Cited by 84
Self-citationCoexistence of MCR-1 and NDM-1 in Clinical Escherichia coli Isolates: Table 1.
Zheng, B., Dong, H., Xu, H., Lv, J., Zhang, J., Jiang, X., Du, Y., Xiao, Y., & Li, L. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw553 · Cited by 82
Daikos, G. L., Markogiannakis, A., Souli, M., & TZOUVELEKIS, L. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.138 · Cited by 80
Global spread of New Delhi mettallo-beta-lactamase-1(NDM-1).
Fallah, F., Taherpour, A., Hakemi-Vala, M., & Hashemi, A. (2011) · Archives of Clinical Infectious Diseases · Cited by 79
Further Spread of blaNDM-5 in Enterobacteriaceae via IncX3 Plasmids in Shanghai, China
Zhang, F., Xie, L., Wang, X., Han, L., Guo, X., Ni, Y., Qu, H., & Sun, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00424 · Cited by 72
Liu, B., Song, F., Zou, M., Hao, Z., & Shan, H. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-16 · Cited by 68
Janvier, F., Jeannot, K., Tessé, S., Robert-Nicoud, M., Delacour, H., Rapp, C., & Mérens, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02334-12 · Cited by 61
Du, H., Chen, L., Chavda, K. D., Pandey, R., Zhang, H., Xie, X., Tang, Y., & Kreiswirth, B. N. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03053-15 · Cited by 60
Mechanisms Involved in Acquisition of bla NDM Genes by IncA/C 2 and IncFII Y Plasmids
Wailan, A. M., Sidjabat, H. E., Yam, W. K., Alikhan, N.-F., Petty, N. K., Sartor, A. L., Williamson, D. A., Forde, B. M., Schembri, M. A., Beatson, S. A., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00368-16 · Cited by 60
NDM-1-producing Enterobacter cloacae and Klebsiella pneumoniae from diabetic foot ulcers in India
Khan, A. U., & Nordmann, P. (2011) · Journal of Medical Microbiology · doi:10.1099/jmm.0.039008-0 · Cited by 55
Self-citationEmergence of NDM – 1 in the Clinical Isolates of Pseudomonas aeruginosa in India
Khajuria, A., Praharaj, A. K., Kumar, M., & Grover, N. (2013) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2013/5509.3137 · Cited by 54
Shen, P., Yi, M., Fu, Y., Ruan, Z., Du, X., Yu, Y., & Xie, X. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01581-16 · Cited by 54
Is it necessary to change the classification of β-lactamases?
Frère, J., Galleni, M., Bush, K., & Dideberg, O. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki155 · Cited by 52
Shrestha, B., Tada, T., Miyoshi‐Akiyama, T., Shimada, K., Ohara, H., Kirikae, T., & Pokhrel, B. M. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00332-15 · Cited by 46
Coexistence of MCR-1 and NDM-9 in a clinical carbapenem-resistant Escherichia coli isolate
Lai, C., Chuang, Y.-C., Chen, C., & Tang, H.-J. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.02.001 · Cited by 45
Khan, A. U., & Rehman, M. T. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01194-15 · Cited by 44
Self-citationDetection systems for carbapenemase gene identification should include the SME serine carbapenemase
Bush, K., Pannell, M., Lock, J. L., Queenan, A. M., Jorgensen, J. H., Lee, R. M., Lewis, J. S., & Jarrett, D. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.008 · Cited by 42
Tada, T., Shrestha, B., Miyoshi‐Akiyama, T., Shimada, K., Ohara, H., Kirikae, T., & Pokhrel, B. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03355-14 · Cited by 36
Paveenkittiporn, W., Kerdsin, A., Chokngam, S., Bunthi, C., Sangkitporn, S., & Gregory, C. J. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.11.005 · Cited by 34
Tada, T., Miyoshi‐Akiyama, T., Shimada, K., & Kirikae, T. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02793-13 · Cited by 32
Vento, S., & Cainelli, F. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60264-4 · Cited by 26
Tran, D. N. M., Tran, H. H., Matsui, M., Suzuki, M., Suzuki, S., Shibayama, K., Pham, T. D., Phuong, T. T. V., Dang, D. A., Trinh, H. S., et al. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2784-8 · Cited by 23
Baiden, F., Owusu‐Agyei, S., Webster, J., & Chandramohan, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60265-6 · Cited by 23
SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
Winkler, M., & Bonomo, R. A. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv235 · Cited by 15
Cited by
Che, Y., Yang, Y., Xu, X., Břinda, K., Polz, M. F., Hanage, W. P., & Zhang, T. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2008731118 · Cited by 344
Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
Husna, A., Rahman, M. M., Badruzzaman, A. T. M., Sikder, M. H., Islam, M. R., Rahman, M. T., Alam, J., & Ashour, H. M. (2023) · Biomedicines · doi:10.3390/biomedicines11112937 · Cited by 337
Critical Importance of a One Health Approach to Antimicrobial Resistance
White, A., & Hughes, J. M. (2019) · EcoHealth · doi:10.1007/s10393-019-01415-5 · Cited by 276
Metadata
- Authors
- Khan, A. U., Maryam, L., & Zarrilli, R.
- Venue
- BMC Microbiology
- Published
- 2017-04-27
- Volume
- 17
- Issue
- 1
- Pages
- 101-101
- ISSN
- 1471-2180 (ISSN-L)
- OpenAlex
- W2607580877
- Cited by
- 512
- References
- 71
- FWCI
- 17.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.